MTI Biotech Inc
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| 2-Hydroxybenzylamine (2-HOBA) Study in Early Alzheimer's Patients (NCT06432166) | MTI Biotech Inc | 2025-09-01 |
Track MTI Biotech Inc automatically
Every clearance here is in the API, with alerts when new ones post.